Inform, Empower, Connect

Osteosarcoma Clinical Trial Update

Osteosarcoma Clinical Trial Update

Every year cancer experts from across the world come together for The American Society of Clinical Oncology Annual Meeting (ASCO). The aim of ASCO is to share knowledge and provide updates on cancer research. By working together we hope to develop new cancer...
A Promising New Bone Cancer Drug

A Promising New Bone Cancer Drug

Researchers at the University of East Anglia have developed a new drug that works against bone cancer including osteosarcoma (OS). The drug, called CADD522, has shown promising results in the laboratory. It will now undergo formal toxicology assessment before...
A Close Look at the Immune Cells in Osteosarcoma

A Close Look at the Immune Cells in Osteosarcoma

In recent years there has been an increase in cancer treatments that target the immune system. So far, these therapies have not been effective in treating osteosarcoma (OS). Researchers are now trying to understand why these treatments are not working. A recent study...